How much funding has Hyasynth raised?

Hyasynth has raised $5.0M in total funding, most recently a Corporate Round.

Where is Hyasynth headquartered?

Hyasynth is headquartered in Montreal, Canada.

Hyasynth

Producing cannabinoids through yeast fermentation

Montreal, Canada · Founded 2014 · $5.0M raised

Biotech

Headquarters: Montreal
Employees: 11–50
Founded: 2014
Business Model: B2B

Website: hyasynthbio.com
Total Funding: $5.0M
Last Round: $2.5M Corporate RoundJan 2022
Rounds: 5

About

Hyasynth Bio is a Montreal-based biotechnology company that produces cannabinoids through yeast fermentation rather than traditional cannabis cultivation. Using a proprietary biosynthesis platform with genetically engineered yeast strains, the company manufactures pure CBD, THC, and other cannabinoids as ingredients for pharmaceutical, nutraceutical, and wellness applications. This fermentation-based approach enables consistent, scalable production without the agricultural inputs required by plant-based extraction.

Summary

Hyasynth is a Biotech company based in Montreal, Canada, founded in 2014. It has raised $5.0M in total across 5 rounds, most recently a $2.5M Corporate Round round in Jan 2022.

LinkedIn X (Twitter)